SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-13-473377
Filing Date
2013-12-13
Accepted
2013-12-13 17:10:38
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 d542253ds3a.htm S-3/A 459251
2 CONSENT OF CHERRY BEKAERT LLP d542253dex231.htm EX-23.1 1645
4 GRAPHIC g542253bc_pg01.jpg GRAPHIC 24430
5 GRAPHIC g542253cov_pg01.jpg GRAPHIC 14537
6 GRAPHIC g542253sabc_pg01a.jpg GRAPHIC 24474
7 GRAPHIC g542253sabc_pg01b.jpg GRAPHIC 16420
8 GRAPHIC g542253sacov_pg01a.jpg GRAPHIC 16734
9 GRAPHIC g542253sacov_pg01b.jpg GRAPHIC 14063
10 filename10.htm CORRESP 6395
  Complete submission text file 0001193125-13-473377.txt   621868
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-192618 | Film No.: 131276891
SIC: 2834 Pharmaceutical Preparations